2007
DOI: 10.1016/s0022-5347(18)30507-x
|View full text |Cite
|
Sign up to set email alerts
|

242: Pharmacogenetics Determinants of Anticancer Activity of Intravescical Gemcitabine in Patients with Superficial Transitional Cell Carcinoma (TCC) of The Bladder

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles